longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

06160

06160
----

LongbridgeAI

BeOne Medicines Chief Executive Officer Sold Shares Worth Over $933K

TradingView
Jun 25, 2026 at 09:20 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

John Oyler, CEO of BeOne Medicines, sold American Depositary Shares totaling $933,592 on June 23, 2026. The sales occurred at weighted average prices between $273.30 and $275.10 per ADS. Following these transactions, Oyler holds 5,605,310 ordinary shares directly and no longer holds ADSs directly, while retaining indirect ownership through trusts.

John Oyler, a director and the Chief Executive Officer, reported a sale of American Depositary Shares at weighted average prices of $273.30, $274.12 and $275.10 per ADS. The total proceeds from the sales were $933,592. The sales consisted of 1,800 ADS, 1,290 ADS and 320 ADS on June 23, 2026. Following the transactions, Oyler directly owns 5,605,310 Ordinary Shares and no longer directly owns American Depositary Shares. Oyler indirectly owns 46,031,994 Ordinary Shares through trusts and related entities referenced in the filing.

Reporter NameOyler John
RelationshipChief Executive Officer
TypeSell
Amount$933,592
SEC FilingForm 4
Disclaimer
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

Login to unlock330characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

BeOne Medicines

BeOne Medicines

SH688235

+3.76%

Beigene

Beigene

USONC

+2.11%

BEONE MEDICINES

BEONE MEDICINES

HK06160

+3.20%